ArticleCancers2023

Real Check RIO: A Real-World Analysis of Nivolumab in First Line Metastatic Melanoma Assessing Efficacy, Safety and Predictive Factors.

Vlad-Adrian Afrăsânie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.